Abstract:Understanding mechanisms of ageing remains a complex challenge for biogerontologists, but recent adaptations of evolutionary ageing theories offer a compelling lens in which to view both age-related molecular and physiological deterioration. Ageing is commonly associated with progressive declines in biochemical and molecular processes resulting from damage accumulation, yet the role of continued developmental gene activation is less appreciated. Natural selection pressures are at their highest in youthful periods to modify gene expression towards maximising reproductive capacity. After sexual maturation, selective pressure diminishes, subjecting individuals to maladaptive pleiotropic gene functions that were once beneficial for developmental growth but become pathogenic later in life. Due to this selective 'shadowing' in ageing, mechanisms to counter such hyper/hypofunctional genes are unlikely to evolve. Interventions aimed at targeting gene hyper/hypofunction during ageing might, therefore, represent an attractive therapeutic strategy. The nematode Caenorhabditis elegans offers a strong model for post-reproductive mechanistic and therapeutic investigations, yet studies examining the mechanisms of, and countermeasures against, ageing decline largely intervene from larval stages onwards. Importantly, however, lifespan extending conditions frequently impair early-life fitness and fail to correspondingly increase healthspan. Here, we consolidate multiple evolutionary theories of ageing and discuss data supporting hyper/hypofunctional changes at a global molecular and functional level in C. elegans, and how classical lifespan-extension mutations alter these dynamics. The relevance of such mutant models for exploring mechanisms of ageing are discussed, highlighting that post-reproductive gene optimisation represents a more translatable approach for C. elegans research that is not constrained by evolutionary trade-offs. Where some genetic mutations in C. elegans that promote late-life health map accordingly with healthy ageing in humans, other widely used genetic mutations that extend worm lifespan are associated with life-limiting pathologies in people. Lifespan has also become the gold standard for quantifying 'ageing', but we argue that gerospan compression (i.e., 'healthier' ageing) is an appropriate goal for anti-ageing research, the mechanisms of which appear distinct from those regulating lifespan alone. There is, therefore, an evident need to re-evaluate experimental approaches to study the role of hyper/hypofunctional genes in ageing in C. elegans.

Caenorhabditis elegans as a Useful Model for Studying Aging Mutations

Caenorhabditis Elegans: the Key to the Secret of Longevity

Caenorhabditis elegans as a Model to Study Aging and Photoaging

Molecular mechanisms of dietary restriction in aging—insights from Caenorhabditis elegans research

A living model for obesity and aging research: Caenorhabditis elegans

Considering Caenorhabditis elegans Aging on a Temporal and Tissue Scale: The Case of Insulin/IGF-1 Signaling

Caenorhabditis elegans in Chinese medicinal studies: making the case for aging and neurodegeneration.

The Nutrients-Regulated Insulin/Igf-1 and Tor Pathways Play an Important Role in C. Elegans Aging

Comprehensive evaluation of lifespan-extending molecules in C. elegans

Caenorhabditis elegans: A Convenient In Vivo Model for Assessing the Impact of Food Bioactive Compounds on Obesity, Aging, and Alzheimer's Disease

Applying C. elegans to the Industrial Drug Discovery Process to Slow Aging

Age‐dependent changes and biomarkers of aging in Caenorhabditis elegans

Caenorhabditis elegans as a Model for the Effects of Phytochemicals on Mitochondria and Aging

Mitochondrial stress and aging: Lessons from C. elegans

Caenorhabditis elegans as a powerful alternative model organism to promote research in genetic toxicology and biomedicine

Consolidating multiple evolutionary theories of ageing suggests a need for new approaches to study genetic contributions to ageing decline

Anti-aging effects of medicinal plants and their rapid screening using the nematode Caenorhabditis elegans

Caenorhabditis elegans as in vivo model for the screening of natural plants-derived novel anti-aging compounds: a short introduction

Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay

Bioactive Phytochemicals with Anti-Aging and Lifespan Extending Potentials in Caenorhabditis elegans

Meta-analytic Insights into the Effects of Different Anti-aging Drugs on Survival Curves of Caenorhabditis elegans